The short explanation
Active surveillance does not mean ignoring the cancer. It is a recognised way of managing early, slow-growing prostate cancer, especially in older men. Many prostate cancers grow so slowly that they would never cause problems during a man's lifetime, while surgery and radiotherapy can cause side effects such as urine leakage and erection problems. In active surveillance, your father will have regular PSA tests, examinations and sometimes repeat MRI scans or biopsies. If there are signs that the cancer is growing or becoming more aggressive, treatment can then be offered. This approach aims to avoid treatment that is not needed while keeping a close watch.
What depends on your situation
The parts of this that change from person to person. Uncertainty is stated, not hidden.
- The decision depends on the cancer's grade and stage, his PSA level, his overall health and his own preferences.
- Some families feel uneasy living with an untreated cancer. It is reasonable to ask the doctor how often checks will happen and what would trigger treatment.
- A second opinion from a urologist or oncologist can help if the family is unsure.
What this answer cannot determine
The boundary of online education. These need a clinician who can see you.
- This cannot tell whether active surveillance is right for your father. His doctors, who know his test results and health, can advise.
Questions for your clinician
Take these with you. You can add any of them to an appointment card.
- Why is active surveillance suitable for him?
- How often will he need PSA tests and scans?
- What changes would mean starting treatment?
- What are the side effects of the treatment options?
When to seek help
Clinician-approved guidance for this topic. When in doubt, being seen is never the wrong choice.
Emergency — call 112 now
- Call 112 or go to an emergency department if he suddenly cannot pass urine, has new weakness in his legs or loss of bladder or bowel control.
Raise it at a routine appointment
- Keep all scheduled monitoring appointments.
Sources
The evidence this explanation is built on.
- Prostate cancer NHS
- Prostate cancer National Cancer Institute (NIH)
- Prostate cancer MedlinePlus (US National Library of Medicine)
Who wrote and reviewed this
Every AskHim answer names its author. A clinically reviewed answer also names the clinician who signed it off — if no clinician is named below, it has not been clinically reviewed.
- Author
- AskHim Editorial (AI-assisted)
- Clinical reviewer
- Nobody yet No clinician has signed this answer off. That is what the “Editorially reviewed” badge means, and why it does not say “Clinically reviewed”. It was written and checked by AskHim’s editorial team against the sources listed above, and it is queued for a clinician who works in this area.
- Review status
- Editorially reviewed
- Last reviewed
- Last reviewed 11 November 2026
- Version
- 1
Correction history
Substantive changes are listed, not quietly edited away.
No corrections have been made since this answer was first published.
Did this answer your question?
Whatever you choose is filed against this version of the answer, never against you, and it is never shown as a count.
“Explain more simply” asks which part was hard to follow, so the author knows what to rewrite. “My question is different” tells the editorial team this answer missed your point, then lets you ask your own question privately. Nothing about you is sent with either.
Saving, following up and reporting are all private. Nothing you do on this page is visible to other readers or to the doctor who wrote it, unless you ask a question.